<--- Back to Details
First PageDocument Content
Research / Rare Diseases Clinical Research Network / NIH Intramural Research Program / National Institute of Diabetes and Digestive and Kidney Diseases / Rare disease / National Heart /  Lung /  and Blood Institute / Clinical trial / National Human Genome Research Institute / RDCRN Contact Registry / National Institutes of Health / Health / Medicine
Date: 2014-12-04 01:13:21
Research
Rare Diseases Clinical Research Network
NIH Intramural Research Program
National Institute of Diabetes and Digestive and Kidney Diseases
Rare disease
National Heart
Lung
and Blood Institute
Clinical trial
National Human Genome Research Institute
RDCRN Contact Registry
National Institutes of Health
Health
Medicine

Microsoft PowerPoint - Steve Groft Newborns and Children Adv 1.pps

Add to Reading List

Source URL: www.hrsa.gov

Download Document from Source Website

File Size: 123,47 KB

Share Document on Facebook

Similar Documents

CURRENT UPDATES ON  PA T H O L O G Y O F LUNG TUMORS

CURRENT UPDATES ON PA T H O L O G Y O F LUNG TUMORS

DocID: 1vn7k - View Document

WSCConference 16 Case 1 – Tissue from a green tree python. MICROSCOPIC DESCRIPTION: Lung(1pt): Faveolar septa are markedly expanded up to 300um. (1pt)There is marked diffuse disorganized (1pt) hyperplasia (1

WSCConference 16 Case 1 – Tissue from a green tree python. MICROSCOPIC DESCRIPTION: Lung(1pt): Faveolar septa are markedly expanded up to 300um. (1pt)There is marked diffuse disorganized (1pt) hyperplasia (1

DocID: 1vmse - View Document

Journal of Infection and Public Health, S31—S34  EGFR mutation testing in non-small cell lung cancer (NSCLC) Fouad Al Dayel 1 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital an

Journal of Infection and Public Health, S31—S34 EGFR mutation testing in non-small cell lung cancer (NSCLC) Fouad Al Dayel 1 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital an

DocID: 1vjEy - View Document

RESEARCH  Efficacy, safety and economy of icotinib for advanced non-small cell lung cancer: a meta-analysis

RESEARCH Efficacy, safety and economy of icotinib for advanced non-small cell lung cancer: a meta-analysis

DocID: 1vfqs - View Document

2017  Acknowledgments The American Lung Association “State of the Air® 2017” is the result of the hard work of many people:

2017 Acknowledgments The American Lung Association “State of the Air® 2017” is the result of the hard work of many people:

DocID: 1vaRd - View Document